Loperamide
Loperamide hydrochloride
Brand names:Imodium, Imodium A-D, Diamode
A peripherally acting opioid receptor agonist that reduces intestinal motility and increases anal sphincter tone, producing antidiarrheal effect without CNS effects at therapeutic doses. Loperamide is operationally critical in deployment and tactical medicine for managing traveler's diarrhea and operational diarrhea that affects mission capability and hydration status.
Pharmacology and Actions
Loperamide binds to mu-opioid receptors in the myenteric plexus of the intestinal wall, inhibiting acetylcholine release and reducing peristalsis. The result is slowed transit time, increased water reabsorption, and reduced stool frequency. At therapeutic doses, loperamide does not cross the blood-brain barrier significantly due to P-glycoprotein efflux, which is why the drug lacks the CNS effects and abuse potential of systemic opioids. Very high doses (recreational misuse) can saturate this transport and produce CNS opioid effects.
Indications
- Acute diarrhea from gastroenteritis or food poisoning
- Traveler's diarrhea (operational tempo preservation)
- Symptomatic relief of chronic diarrhea
- Operational mission completion when diarrhea would compromise capability
- Diarrhea management when toilet access is limited (tactical operations, transport)
Absolute Contraindications
- Known loperamide allergy
- Bloody diarrhea or diarrhea with high fever (suggests invasive bacterial infection)
- Suspected pseudomembranous colitis or Clostridioides difficile infection
- Acute ulcerative colitis flare (risk of toxic megacolon)
- Children under 2 years
- Diarrhea associated with broad-spectrum antibiotic use (relative; rule out C. difficile)
Precautions and Side Effects
Generally well tolerated at therapeutic doses. Constipation, abdominal pain, nausea, and dizziness can occur. Cardiac arrhythmias including torsades de pointes have been reported with overdose and high-dose recreational use; FDA issued warnings in 2016 and 2018. Avoid use when invasive bacterial infection is suspected; slowing transit can prolong infection and worsen outcomes. Paralytic ileus can occur with excessive doses or in susceptible patients.
Adult Dosing
Pediatric Dosing
Pediatric dosing varies by weight and age, generally restricted to patients 6 years and older. 6 to 8 years (22 to 27 kg): 2 mg first day, then 1 mg after each loose stool. 9 to 11 years (27 to 43 kg): 2 mg first day, then 1 mg after each loose stool. 12 years and older: adult dosing. CONTRAINDICATED in children under 2 years.
Pharmacokinetics
Peak Effect: PO: 4 to 5 hours
Duration: 9 to 14 hours per dose
Storage and Handling
Store tablets, capsules, and liquid at controlled room temperature (15 to 30 degrees Celsius). Protect from moisture. Stable in deployment and field kit environments.
Reconstitution:
Tablets, capsules, and liquid require no reconstitution.
TCCC and TECC Role
Loperamide is a deployment medicine and tactical medicine staple for managing the operational diarrhea that develops from food, water, or stress in field environments. The drug allows mission completion in scenarios where uncontrolled diarrhea would compromise capability or hydration. Loperamide pairs with rehydration therapy and, when bacterial infection is suspected, with appropriate antibiotic coverage (azithromycin, ciprofloxacin, or other agents). The 2 to 4 mg initial dose works fast and the operational return-to-duty timing is favorable.
Loperamide is the drug that addresses the operational reality of traveler's diarrhea and food poisoning during missions. The 2 to 4 mg initial dose stops most non-invasive diarrhea within 1 to 2 hours, allowing the operator to continue mission while addressing hydration. The critical assessment is whether the diarrhea is from a non-invasive source (viral, non-invasive bacterial, food intolerance) or an invasive bacterial infection (Shigella, Salmonella, invasive E. coli, Campylobacter). Bloody stools, high fever, or significant abdominal pain suggest invasive infection; in those cases, loperamide is contraindicated and antibiotics with rehydration are the right approach.
Using loperamide for bloody diarrhea or diarrhea with high fever. These features suggest invasive bacterial infection where slowing intestinal transit prolongs pathogen contact and can worsen outcomes. The other common error is high-dose recreational use, which the FDA has warned can cause cardiac arrhythmias including torsades de pointes. Stick to labeled doses; the therapeutic effect plateaus quickly at recommended doses.
This drug profile is provided as educational reference material for trained medical providers. It is not medical advice, not a substitute for formal training, and not a substitute for current published guidelines or medical direction.
Drug administration is governed by your scope of practice, agency standing orders, medical director protocols, and applicable state and federal regulations. Controlled substances are subject to additional handling, accountability, and documentation requirements per DEA and state law. Always verify dosing, indications, contraindications, and route of administration against current published guidelines and your local protocols before administration.
If this content is being viewed during a medical emergency, call 911 immediately and follow the direction of your local emergency dispatch and medical control. Do not use this reference as a substitute for emergency medical services.
Drug information evolves. Last reviewed dates and source citations are provided for each entry. Confirm currency against the cited source before clinical use.
Penn Tactical Solutions publishes this reference for educational purposes. PTS does not provide medical direction and does not assume responsibility for clinical decisions made in the field. Clinical responsibility rests with the administering provider, their medical director, and their agency.
Educational reference for trained medical providers. Not medical advice. Not a substitute for formal training, current published guidelines, or medical direction. Drug administration is governed by your scope of practice, agency standing orders, medical director protocols, and applicable state and federal regulations. Controlled substances require additional storage, accountability, and documentation per DEA and state law.
In a medical emergency, call 911. This reference is not a substitute for emergency medical services.
Verify dosing, indications, and contraindications against current published guidelines and your local protocols before administration. Confirm content currency against the source citation. Penn Tactical Solutions does not provide medical direction. Clinical responsibility rests with the administering provider, their medical director, and their agency.
Loperamide
| PO | Acute diarrhea: 4 mg PO initially, then 2 mg after each loose stool. Maximum 16 mg/24 hours (prescription) or 8 mg/24 hours (OTC). Traveler's diarrhea: 4 mg initially, then 2 mg after each loose stool for up to 2 days. Continue antibiotic therapy if indicated for the underlying infection. (30 to 60 minutes) |